Cover image of the article: Cystic fibrosis anddistribution and mutation analysis of CFTR gene in Iranian patients

Image Credit:Koomesh

Cystic fibrosis anddistribution and mutation analysis of CFTR gene in Iranian patients

Authors

Mohammad Reza Havasian, Jafar Panahi, Nejat Mahdieh,*
*Corresponding Author: Email: nmahieh@yahoo.com

Koomesh:Vol. 15, issue 4; 431-440
Published online:May 28, 2014
Article type:Research Article
Received:Sep 02, 2013
Accepted:Jan 02, 2014
How to Cite:Havasian MR, Panahi J, Mahdieh N. Cystic fibrosis anddistribution and mutation analysis of CFTR gene in Iranian patients. koomesh. 2014;15(4):e152879. doi:

Abstract

 Cystic fibrosis is one of the most lethal multi-system disorders and is the most common autosomal recessive disease in Caucasians. The related protein is named cystic fibrosis transmembrane conductive regulator (CFTR). Various mutations in CFTR gene have been reported to cause CFTR loss of function and diseased phenotype. The most prevalent mutation is ΔF508, deletion of phe at position 508. Here, we briefly explain clinical features and diagnostic methods of the disease firstly, and then the genetics of the disease and its mutations as well as genetic studies in Iranian populations are reviewed. Up to now, totally 56 different mutations have been reported in Iranian patients which 8 of them reported for the first time. Seven common mutations in this population are as follows p.F508del (33.33%), c.1677delTA (7.41%), c.2183_2184delAAinsG (5.56%), p.N1303K (4.81%), c.2789+5G>A (4.44%), p.S466X (4.44%) and p.G542X (4.07%). 

Highlights

Copyright

© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

17
Jan
2013
Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran

Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran

Shirin Farjadian,
Mozhgan Moghtaderi,
Sara Kashef,
Soheila Alyasin,
Khadijehsadat Najib,
Forough Saki

Farjadian S, Moghtaderi M, Kashef S, Alyasin S, Najib K, et al. Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran. Inn J Pediatr. 2013;23(2):. doi:

19
Mar
2017
The molecular analysis of mutations in exons 4, 11 and 21 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis patients in Kermanshah, Iran

The molecular analysis of mutations in exons 4, 11 and 21 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis patients in Kermanshah, Iran

Nasibe Karimi,
Ali Bidmeshkipour,
Keyghobad Ghadiri,
Reza Alibakhshi

Karimi N, Bidmeshkipour A, Ghadiri K, Alibakhshi R. The molecular analysis of mutations in exons 4, 11 and 21 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis patients in Kermanshah, Iran. J Kermanshah Univ Med Sci. 2017;20(4):e69663. doi: https://doi.org/10.22110/jkums.v20i4.2466

23
Dec
2015
Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency

Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency

Ahmad Khodadad,
Elaheh Elahi,
Setareh Sadat Bani Hassani,
Pejman Rouhani,
Bamdad Sadeghi,
Nima Rezaei

Khodadad A, Elahi E, Bani Hassani SS, Rouhani P, Sadeghi B, et al. Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency. Inn J Pediatr. 2015;25(6):e3419. doi: https://doi.org/10.5812/ijp.3419

21
May
2009
Analysis of CFTR gene mutations in Iranian non - obstructive azoospermic patients

Analysis of CFTR gene mutations in Iranian non - obstructive azoospermic patients

Reza Mirfakhraie,
SM Kalantar,
n Salsabili,
Maryam Montazeri,
h Fazli,
Massoud Houshmand
,et al.

Mirfakhraie R, Kalantar S, Salsabili N, Montazeri M, Fazli H, et al. Analysis of CFTR gene mutations in Iranian non - obstructive azoospermic patients. Zahedan J Res Med Sci. 2008;10(4):e94501. doi:

1
Nov
2013
Clinical Scoring Systems in Cystic Fibrosis – What Are the Options for Developing Countries?

Clinical Scoring Systems in Cystic Fibrosis – What Are the Options for Developing Countries?

Brenda Morrow

Morrow B. Clinical Scoring Systems in Cystic Fibrosis – What Are the Options for Developing Countries?. J Compr Ped. 2013;4(4):e93768. doi: https://doi.org/10.17795/compreped-13158

More by these authors

Mohammad Reza HavasianPubMedScholar
Jafar PanahiPubMedScholar
Nejat MahdiehPubMedScholar
Share
Cited by
Metrics